X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ophthalmology (304) 304
ranibizumab (272) 272
humans (266) 266
macular degeneration (223) 223
bevacizumab (213) 213
vascular endothelial growth factor (193) 193
intravitreal injections (171) 171
vascular endothelial growth factor a - antagonists & inhibitors (157) 157
aflibercept (155) 155
endothelial growth-factor (133) 133
male (128) 128
female (126) 126
aged (112) 112
angiogenesis inhibitors - therapeutic use (105) 105
diabetic retinopathy (101) 101
genetic structures (101) 101
recombinant fusion proteins - therapeutic use (97) 97
anti-vegf (92) 92
treatment outcome (92) 92
eye diseases (90) 90
vegf (90) 90
age-related macular degeneration (87) 87
choroidal neovascularization (87) 87
vegf trap-eye (86) 86
receptors, vascular endothelial growth factor - therapeutic use (83) 83
retina (83) 83
tomography, optical coherence (80) 80
wet macular degeneration - drug therapy (78) 78
middle aged (75) 75
age (74) 74
vegf-trap (73) 73
patients (71) 71
recombinant fusion proteins - administration & dosage (71) 71
aged, 80 and over (70) 70
visual acuity (68) 68
angiogenesis inhibitors - administration & dosage (67) 67
edema (67) 67
care and treatment (66) 66
receptors, vascular endothelial growth factor - administration & dosage (66) 66
physiological aspects (65) 65
macular edema - drug therapy (63) 63
angiogenesis (61) 61
sense organs (61) 61
diabetic macular edema (60) 60
follow-up studies (59) 59
injection (59) 59
macular degeneration - drug therapy (59) 59
eye (57) 57
animals (56) 56
retrospective studies (54) 54
pharmacology & pharmacy (53) 53
visual acuity - physiology (53) 53
diabetes (52) 52
intravitreal aflibercept (52) 52
neovascularization (52) 52
therapy (52) 52
analysis (50) 50
medicine & public health (49) 49
vegf trap (49) 49
fluorescein angiography (48) 48
research (48) 48
clinical trials (47) 47
studies (47) 47
antibodies, monoclonal, humanized - therapeutic use (45) 45
choroidal neovascularization - drug therapy (45) 45
drug therapy (44) 44
review (44) 44
wet macular degeneration - diagnosis (44) 44
acuity (42) 42
prospective studies (42) 42
diabetic retinopathy - drug therapy (41) 41
photodynamic therapy (40) 40
retinopathy (40) 40
recombinant fusion proteins - adverse effects (39) 39
medical research (36) 36
ranibizumab - administration & dosage (36) 36
efficacy (35) 35
endothelial growth factors (35) 35
time factors (35) 35
angiogenesis inhibitors - adverse effects (34) 34
wet macular degeneration - physiopathology (33) 33
intravitreal injection (31) 31
optical coherence tomography (31) 31
anti-vegf therapy (30) 30
vascular endothelial growth factor a - metabolism (30) 30
verteporfin (30) 30
visual acuity - drug effects (29) 29
lasers (28) 28
macular edema (28) 28
prevalence (28) 28
ranibizumab - therapeutic use (28) 28
expression (27) 27
outcomes (27) 27
safety (27) 27
macular edema - etiology (26) 26
medicine, experimental (26) 26
surgery (26) 26
visual-acuity (26) 26
degeneration (25) 25
intravitreal bevacizumab (25) 25
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 6, pp. 1098 - 1106
Journal Article
Ophthalmology, ISSN 0161-6420, 2009, Volume 116, Issue 11, pp. 2141 - 2148.e1
Journal Article
Ophthalmology, ISSN 0161-6420, 2011, Volume 118, Issue 6, pp. 1089 - 1097
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2014, Volume 121, Issue 7, pp. 1414 - 1420.e1
... of intravitreal anti-VEGF agents for treatment of macular edema secondary to CRVO.10–13 Intravitreal aflibercept (known in the scientific literature as VEGF Trap-Eye... 
Ophthalmology | TRIAL | BEVACIZUMAB | PHASE-III | SECONDARY | OPHTHALMOLOGY | VEGF TRAP-EYE | RANIBIZUMAB | Dropsy | Edema | Retinal diseases | Consulting services
Journal Article
Journal Article
Expert Review of Clinical Pharmacology, ISSN 1751-2433, 03/2013, Volume 6, Issue 2, pp. 103 - 113
Journal Article
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 2016, Volume 123, Issue 3, pp. 617 - 624
Purpose To investigate changes in subfoveal choroidal thickness after intravitreal aflibercept injections (IAIs) for neovascular age-related macular... 
Ophthalmology | VERTEPORFIN | OPTICAL COHERENCE TOMOGRAPHY | HEALTHY-SUBJECTS | OPHTHALMOLOGY | DIURNAL-VARIATION | VEGF TRAP-EYE | RANIBIZUMAB | VASCULOPATHY | Macular degeneration | Care and treatment
Journal Article
Ophthalmology (Rochester, Minn.), ISSN 0161-6420, 10/2015, Volume 122, Issue 10, pp. 2044 - 2052
Journal Article
Expert Review of Ophthalmology, ISSN 1746-9899, 10/2011, Volume 6, Issue 5, pp. 513 - 516
Evaluation of: Brown DM, Heier JS, Ciulla T et al. Primary end point results of a Phase II study of vascular endothelial growth factor trap-eye in wet age-related macular degeneration. Ophthalmology 118(6), 1089-1097 (2011... 
intravitreal therapy | choroidal neovascularization | age-related macular degeneration | VEGF Trap-Eye | Intravitreal therapy | Choroidal neovascularization | Age-related macular degeneration | Macular degeneration | Physiological aspects | Ophthalmology | Endothelial growth factors | Vascular endothelial growth factor | Endothelium
Journal Article
Ophthalmology, ISSN 0161-6420, 2017, Volume 124, Issue 5, pp. 667 - 673
Topic The purpose of this study was to identify changes in use for vitreoretinal procedures by measuring the number of allowed services using data from the US... 
Ophthalmology | OPHTHALMOLOGY | MACULAR DEGENERATION | VEGF TRAP-EYE | EDEMA | Medicare Part B | Insurance Benefits | United States | Humans | Retrospective Studies | Forecasting | Ophthalmologic Surgical Procedures - trends | Retinal Diseases - surgery | Vitreous Body - surgery | Medicare | Medical colleges | Beneficiaries | Analysis
Journal Article
Journal Article
Drug design, development and therapy, ISSN 1177-8881, 2013, Volume 7, pp. 711 - 722
Background: Vascular endothelial growth factor (VEGF) is a naturally occurring glycoprotein in the body that acts as a growth factor for endothelial cells. It... 
AMD | Neovascularization | VEGF-Trap eye | Aflibercept | VEGF | VEGF inhibition | DIABETIC-RETINOPATHY | DA VINCI | CHEMISTRY, MEDICINAL | aflibercept | TYROSINE KINASE | neovascularization | VASCULAR-PERMEABILITY | PEGAPTANIB SODIUM | MACULAR EDEMA SECONDARY | PHARMACOLOGY & PHARMACY | INTRAVITREAL BEVACIZUMAB | VEGF TRAP-EYE | POLYPOIDAL CHOROIDAL VASCULOPATHY | ENDOTHELIAL GROWTH-FACTOR | Antibodies, Monoclonal, Humanized - therapeutic use | Receptors, Vascular Endothelial Growth Factor - therapeutic use | Intravitreal Injections | Recombinant Fusion Proteins - pharmacology | Humans | Receptors, Vascular Endothelial Growth Factor - pharmacology | Recombinant Fusion Proteins - therapeutic use | Wet Macular Degeneration - physiopathology | Clinical Trials as Topic | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Animals | Wet Macular Degeneration - drug therapy | Choroidal Neovascularization - drug therapy | Choroidal Neovascularization - pathology | Ranibizumab | Recombinant Fusion Proteins - administration & dosage | Macular degeneration | Pharmaceutical research | Physiological aspects | Research | Drug therapy | Vascular endothelial growth factor | Medical research | Diabetic retinopathy | Retinopathy | Effectiveness | Diabetes mellitus | Clinical trials | Risk reduction | Durability | Retina | Visual acuity | Pharmacology | Glycoproteins | Permeability | Chemical compounds | Two phase | Endothelial cells | Vascularization | Acuity | Eye | Angiogenesis | Growth factors | Age
Journal Article
by Ogura, Yuichiro and Roider, Johann and Korobelnik, Jean-François and Holz, Frank G and Simader, Christian and Schmidt-Erfurth, Ursula and Vitti, Robert and Berliner, Alyson J and Hiemeyer, Florian and Stemper, Brigitte and Zeitz, Oliver and Sandbrink, Rupert and Gillies, Mark and Arnold, Jennifer and McAllister, Ian and Chen, Simon and Mitchell, Paul and Lim, Lyndell and Schoenherr, Ulrich and Priglinger, Siegfried and Devin, François and Paques, Michel and Quentel, Gabriel and Weber, Michel and Creuzot-Garcher, Catherine and Holz, Frank and Aisenbrey, Sabine and Hansen, Lutz Lothar and Wiedemann, Peter and Lohmann, Chris Patrick and Pfeiffer, Norbert and Dithmar, Stefan and Sandner, Dirk and Kirchhof, Bernd and Sachs, Helmut and Grisanti, Salvatore and Feltgen, Nicolas and Emmerich, Karl Heinz and Hattenbach, Lars-Olaf and Walter, Peter and Engelmann, Katrin and Bornfeld, Norbert and Gamulescu, Andreea and Richard, Gisbert and Seitz, Berthold and Mennel, Stefan and Pauleikhoff, Daniel and Koch, Frank and Papp, András and Györy, József Ferenc and Kerényi, Ágnes and Seres, András and Berta, András and Szalczer, Lajos and Boscia, Francesco and Giovannini, Alfonso and Menchini, Ugo and Ricci, Frederico and Varanno, Monica and Viola, Francesco and Lattanzio, Rosangela and Reibaldi, Alfredo and Grignolo, Frederico and Honda, Miki and Terasaki, Hiroko and Yoshimura, Nagahisa and Yuzawa, Mitsuko and Kamei, Motohiro and Zarinova, Ilze and Laganovska, Guna and Mathur, Ranjana and Chee, Caroline and Nam, Dong-Heun and Woo, Se-Joon and Yoon, Young-Hee and Lee, Won-Ki and Yu, Hyeong-Gon and Koh, Hyoung-Jun and GALILEO Study Group and Galileo Study Grp
American journal of ophthalmology, ISSN 0002-9394, 2014, Volume 158, Issue 5, pp. 1032 - 1038.e2
Journal Article